Alliance for Artificial Intelligence in Healthcare (AAIH) Sponsoring Panel at Biotech Showcase as Part of Official AAIH Launch
Wednesday, 02 January 2019 00:06
Jan. 2, 2019 10:30 UTC

Alliance for Artificial Intelligence in Healthcare (AAIH) Sponsoring Panel at Biotech Showcase as Part of Official AAIH Launch

WASHINGTON--(BUSINESS WIRE)-- The newly formed Alliance for Artificial Intelligence in Healthcare (AAIH) is sponsoring a panel discussion open to the public, titled “The Future of AI-Powered Healthcare,” on Monday, January 7, in association with the Digital and Medtech Medicine Showcase at the Biotech Showcase in San Francisco. Experts will explore not only the potential impact of machine learning on healthcare systems and drug development, but also provide insights on what investors and partners should consider before engaging in financing or co-development with AI healthcare companies.

Preceding the panel, Alex Zhavoronkov, CEO of Insilico Medicine, will provide an introduction, announcing the official launch of AAIH, which will include the organization’s inaugural board meeting on Wednesday, January 9, in San Francisco.

WHO: Panelists are Alex Lash, National Biotech Editor, Xconomy; Brandon Allgood, CTO and Co-founder of Numerate; John Baldoni, Senior VP of In-Silico Drug Discovery, GSK; Maria Luisa Pineda, CEO and Co-Founder, Envisagenics; Bill Martin, President and COO, BlackThorn Therapeutics; Angeli Moeller, Co-Lead of AI, Head of Research IT Business Partnering, Bayer; and Ben Newton, CDO, GE Healthcare Life Sciences.

WHAT: The Future of AI-Powered Healthcare session and reception.
WHEN: Monday, January 7, 4 pm
WHERE: Parc 55 San Francisco, 55 Cyril Magnin Street; 4th Floor, Cyril Magnin Ballroom

All media interested in attending should register here. Media interested in speaking with panelists and AAIH founding members should contact Charles Craig, Opus Biotech Communications, [email protected], 404-245-0591; or Dan Eramian, Opus Biotech Communications, [email protected], 425-306-8716.

Contacts

Opus Biotech Communications
Charles Craig, 404-245-0591
[email protected]

Opus Biotech Communications
Dan Eramian, 425-306-8716
[email protected]


Source: Alliance for Artificial Intelligence in Healthcare




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter